Chronic nicotine treatment delays the developmental increase in brain muscarinic receptors in rat neonate

Brain Research

Volumn 732, Issue 1-2, 1996, Pages 257-260

  Zhu, Jun ^a   Takita, Manabu ^a   Konishi, Yukuo ^a   Sudo, Masakatsu ^a   Muramatsu, Ikunobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

brain; chronic treatment; development; muscarinic receptor; nicotine; nicotinic receptor

Indexed keywords

MUSCARINIC RECEPTOR; NICOTINE; NICOTINIC RECEPTOR;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN STEM; CONTROLLED STUDY; FEMALE; LACTATION; NEWBORN; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0010609423     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00704-4     Document Type: Article

References (25)

1. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
2. Butler N.R., Goldstein H. Smoking in pregnancy and subsequent child development. Br. Med. J. 4:1973;573-574.
3. 3H]nicotine binding sites in fetal human brain. Brain Res. 475:1988;1-7.
4. Caulfield M.P. Muscarinic receptors - characterization, coupling and function. Pharm. Ther. 58:1993;319-379.
5. Fried P.A., Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes and alcohol. J. Dev. Behav. Pediatr. 11:1990;49-58.
6. 3H]nicotine binding in the fetal brain. Int. J. Dev. Neurosci. 3:1985;567-571.
7. Lajtha A. Nicotine effects on protein synthesis during development jtInt. J. Dev. Neurosci. 3:1985;445.
8. Lajtha A., Sershen H. Efects of maternal nicotine administration on fetal brain protein turnover. Trans. Am. Soc. Neurochem. 17:1986;253.
9. Lane-Petter, W., The laboratory rat. In R.N. T-W-Fiennes, F.A. Harrison, P. Ray and W.N. Scott (Eds.), The UFAW Handbook on the Care and Management of Laboratory Animals, Churchill Livingstone, New York, 1976, pp. 210-217.
10. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., Widmer H.R. Prenatal adverse effects of nicotine on the developing brain. Prog. Brain Res. 73:1988;137-157.
11. Longo L.O. The biological effects of carbon monoxide on the pregnant woman, fetus, and newborn infant. Am. J. Obstet. Gynecol. 129:1977;69-103.
12. Marks M.J., Stitzel J.A., Collins A.C. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. Pharmacol. Exp. Ther. 235:1985;619-628.
13. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
14. 3H]nicotine binding sites in rat brain regions: an autoradiographic study. Dev. Brain Res. 68:1992;163-174.
15. Nasrat H.A., Al-Hachim G.M., Mahmood F.A. Perinatal effects of nicotine. Biol. Neonate. 49:1986;8-14.
16. Navarro H.A., Seidler F.J., Eylers J.P., Baker F.E., Dobbins S.S., Lappi S.E., Slotkin T.A. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J. Pharmacol. Exp. Ther. 251:1989;894-900.
17. 3H]cytisine binding to nicotinic cholinergic receptors in brain. Mol. Pharmacol. 39:1991;9-12.
18. Sanderson E.M., Drasdo A.L., McCrea K., Wonnacott S. Up-regulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific. Brain Res. 617:1993;349-352.
19. Schlumpf M., Palacios J.M., Cortes R., Lichtensteiger W. Regional development of muscarinic cholinergic binding sites in the prenatal rat brain. Neuroscience. 45:1991;347-357.
20. 3H]nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions. J. Pharmacol. Exp. Ther. 242:1987;232-237.
21. Takita M., Muramatsu I. Alteration of brain nicotinic receptors induced by immobilization stress and nicotine in rats. Brain Res. 681:1995;190-192.
22. Waelbroeck M., Tastenoy M., Camus J., Christophe J. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol. Pharmacol. 38:1990;267-273.
23. Wei J., Walton E.A., Milici A., Buccafusco J.J. m1-m5 Muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. J. Neurochem. 63:1994;815-821.
24. Yamanaka K., Muramatsu I., Kigoshi S. Muscarinic agonist binding in rat brain following chronic nicotine treatment. Brain Res. 409:1987;395-397.
25. Yamanaka K., Oshita M., Muramatsu I. Alteration of alpha and muscarinic receptors in rat brain and heart following chronic nicotine treatment. Brain Res. 348:1985;241-248.